CN Stock MarketDetailed Quotes

600535 Tasly Pharmaceutical Group

Watchlist
  • 14.65
  • +0.12+0.83%
Market Closed Nov 29 15:00 CST
21.89BMarket Cap24.83P/E (TTM)

Tasly Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tasly Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.09B
--
-4.06%
EPS
0.21
0.12
-0.09
Miss Est.
-4.55%
-45.45%
-42.86%
Analyst Rating
Strong Buy

Nov 30, 2024

Tasly Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--
DatePeriodRevenue/EstimateEarnings Call
Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--

Unlock Free Earnings Estimates

Tasly Pharmaceutical Group Earnings Reports

  • Tianshili\'s announcement on the company\'s main operating data for the first three quarters of 2024

    Oct 26 00:00

  • Tasly 2024 Third Quarter Report

    Oct 26 00:00

  • tasly pharmaceutical group 2024 interim report

    Aug 24 00:00

  • Summary of Tasly Pharmaceutical Group's 2024 Interim Report

    Aug 24 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Strong Buy

      72.22%

    • Buy

      27.78%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data